35.40
price up icon1.55%   0.54
after-market Dopo l'orario di chiusura: 35.67 0.27 +0.76%
loading
Precedente Chiudi:
$34.86
Aprire:
$35.12
Volume 24 ore:
64,371
Relative Volume:
1.16
Capitalizzazione di mercato:
$427.91M
Reddito:
$9.71M
Utile/perdita netta:
$-29.96M
Rapporto P/E:
-10.17
EPS:
-3.48
Flusso di cassa netto:
$-14.79M
1 W Prestazione:
+8.26%
1M Prestazione:
+29.91%
6M Prestazione:
+68.65%
1 anno Prestazione:
+24.65%
Intervallo 1D:
Value
$34.40
$35.99
Intervallo di 1 settimana:
Value
$32.01
$35.99
Portata 52W:
Value
$18.35
$35.99

Xoma Royalty Corp Stock (XOMA) Company Profile

Name
Nome
Xoma Royalty Corp
Name
Telefono
510-204-7239
Name
Indirizzo
2200 POWELL STREET, EMERYVILLE, CA
Name
Dipendente
13
Name
Cinguettio
@xomacorp
Name
Prossima data di guadagno
2025-08-08
Name
Ultimi documenti SEC
Name
XOMA's Discussions on Twitter

Confronta XOMA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
XOMA
Xoma Royalty Corp
35.40 420.17M 9.71M -29.96M -14.79M -3.48
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-17 Iniziato The Benchmark Company Buy
2024-04-29 Iniziato Leerink Partners Outperform
2021-09-07 Downgrade Wedbush Outperform → Neutral
2021-06-29 Iniziato Aegis Capital Buy
2021-01-19 Reiterato H.C. Wainwright Buy
2018-01-18 Reiterato H.C. Wainwright Buy
2017-10-17 Ripresa H.C. Wainwright Buy
2017-09-05 Aggiornamento Wedbush Neutral → Outperform
2017-06-12 Iniziato H.C. Wainwright Buy
2016-11-14 Downgrade Wedbush Outperform → Neutral
2016-03-11 Reiterato Wedbush Outperform
2015-07-23 Downgrade Jefferies Buy → Hold
2015-07-22 Downgrade Ladenburg Thalmann Buy → Neutral
2015-07-22 Downgrade Piper Jaffray Overweight → Neutral
2014-10-10 Ripresa ROTH Capital Buy
2014-04-29 Aggiornamento MLV & Co Hold → Buy
2014-03-11 Downgrade MLV & Co Buy → Hold
2014-03-05 Reiterato Ladenburg Thalmann Buy
2013-10-31 Reiterato MLV & Co Buy
2013-05-09 Reiterato Ladenburg Thalmann Buy
2012-05-14 Iniziato Cowen & Co Outperform
2011-03-31 Reiterato MLV Capital Buy
2011-03-23 Reiterato RBC Capital Mkts Outperform
2011-01-06 Reiterato Ladenburg Thalmann Buy
2011-01-04 Reiterato Wedbush Outperform
Mostra tutto

Xoma Royalty Corp Borsa (XOMA) Ultime notizie

pulisher
Sep 03, 2025

What does recent volatility data suggest for XOMA Royalty CorporationBull Run & Stepwise Swing Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

XOMA Royalty Corporation Executives to Present Company Update at H.C. Wainwright 27th Annual Global Investment Conference - Quiver Quantitative

Sep 03, 2025
pulisher
Sep 03, 2025

XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire

Sep 03, 2025
pulisher
Sep 03, 2025

Statistical indicators supporting XOMA Royalty Corporation’s strength2025 Trade Ideas & Reliable Intraday Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can volume confirm reversal in XOMA Royalty Corporation2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is XOMA Royalty Corporation stock reversal real or fakeWeekly Investment Recap & AI Optimized Trading Strategy Guides - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to track smart money flows in XOMA Royalty CorporationMarket Risk Summary & Daily Market Momentum Tracking - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What Fibonacci levels say about XOMA Royalty Corporation reboundPortfolio Growth Summary & High Conviction Buy Zone Picks - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Is XOMA Royalty Corporation forming higher highs and higher lows2025 Stock Rankings & Weekly High Conviction Ideas - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Heatmap analysis for XOMA Royalty Corporation and competitors2025 Institutional Moves & Weekly Setup with High ROI Potential - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How hedge fund analytics apply to XOMA Royalty Corporation stockWatch List & Weekly Breakout Stock Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What to do if you’re stuck in XOMA Royalty CorporationLayoff News & Daily Growth Stock Investment Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What to expect from XOMA Royalty Corporation in the next 30 daysAnalyst Upgrade & Stock Market Timing Techniques - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can XOMA Royalty Corporation weather a recessionJuly 2025 Recap & Stepwise Trade Signal Implementation - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Is XOMA Royalty Corporation stock a falling knife or bargain buyJuly 2025 Movers & Verified Momentum Stock Ideas - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Published on: 2025-09-02 07:26:44 - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Is XOMA Royalty Corporation stock a buy or sell2025 Price Momentum & Daily Profit Maximizing Tips - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Tools to assess XOMA Royalty Corporation’s risk profile2025 Support & Resistance & Free Technical Pattern Based Buy Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

What are XOMA Royalty Corporation’s earnings expectationsWeekly Trade Summary & Safe Entry Zone Identification - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Here's Why XOMA Royalty (XOMA) Is a Great 'Buy the Bottom' Stock Now - ca.finance.yahoo.com

Sep 01, 2025
pulisher
Sep 01, 2025

How to use Fibonacci retracement on XOMA Royalty CorporationWeekly Gains Summary & Consistent Profit Focused Trading Strategies - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

How to read the order book for XOMA Royalty Corporation2025 EndofYear Setup & Verified Chart Pattern Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Can you recover from losses in XOMA Royalty CorporationGDP Growth & Weekly Chart Analysis and Guides - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

XOMA Royalty Corporation stock retracement – recovery analysisWeekly Stock Summary & Short-Term Trading Opportunity Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using economic indicators to assess XOMA Royalty Corporation potentialTrend Reversal & Weekly High Conviction Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is XOMA Royalty Corporation forming higher highs and higher lows getLinesFromResByArray error: size == 0 - sisain.net

Aug 31, 2025
pulisher
Aug 30, 2025

Will XOMA Royalty Corporation see short term momentumJuly 2025 Momentum & Weekly Breakout Stock Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Should you wait for a breakout in XOMA Royalty CorporationJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Will breakout in XOMA Royalty Corporation lead to full recoveryEarnings Risk Summary & Reliable Trade Execution Plans - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Real time pattern detection on XOMA Royalty Corporation stock2025 Big Picture & Safe Entry Zone Identification - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Published on: 2025-08-29 16:44:29 - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Deal Watch: XOMA Buys Troubled Alkermes-Spinout Mural Oncology - insights.citeline.com

Aug 29, 2025
pulisher
Aug 29, 2025

Using Bollinger Bands to evaluate XOMA Royalty Corporation2025 Bull vs Bear & Safe Capital Growth Tips - Newser

Aug 29, 2025

Xoma Royalty Corp Azioni (XOMA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Xoma Royalty Corp Azioni (XOMA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Hughes Owen
Chief Executive Officer
May 19 '25
Option Exercise
0.00
53,359
0
88,338
Hughes Owen
Chief Executive Officer
May 20 '25
Sale
25.38
25,637
650,667
62,701
BURNS THOMAS M.
SVP, Finance & CFO
May 19 '25
Option Exercise
0.00
17,773
0
33,045
BURNS THOMAS M.
SVP, Finance & CFO
May 20 '25
Sale
25.38
10,482
266,033
22,563
BVF PARTNERS L P/IL
10% Owner
May 16 '25
Sale
27.10
392,723
10,642,793
1,267,545
Sitko Bradley
Chief Investment Officer
Apr 07 '25
Buy
24.70
2,000
49,400
5,045
LIMBER JOSEPH M
Director
Apr 03 '25
Buy
25.24
17,935
452,631
16,524
LIMBER JOSEPH M
Director
Apr 04 '25
Buy
25.40
6,822
173,293
20,000
LIMBER JOSEPH M
Director
Apr 07 '25
Buy
25.60
5,243
134,221
10,000
Sitko Bradley
Chief Investment Officer
Mar 31 '25
Buy
21.04
1,245
26,201
11,484
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):